SCHEMBL1890334

SCHEMBL1890334

CCCCCCCCCCC(O)(CCCCCCCCCC)C(O)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
FDPS P14324 8/20 0.41
GGPS1 O95749 5/20 0.41
CYP2D6 P10635 2/20 0.39
SPHK1 Q9NYA1 1/20 0.39
GMNN O75496 1/20 0.39
POLB P06746 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
BLM P54132 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CETP P11597 1/20 0.39
HTT P42858 1/20 0.39
UBE2N P61088 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28434703 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL18863212 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL5820256 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL25815 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL142854 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL2226505 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL5963212 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL139952 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL136611 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1
SCHEMBL29064953 1.00 LMNA (0.41) LMNAFDPSGGPS1CYP2D6SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160009619-A1 POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME DAICEL CORPORATION (JP) 2016-01-14 US disclosed
EP-2048544-B1 Toner, developer and image forming method RICOH CO LTD (JP) 2015-03-25 EP disclosed
EP-2813483-A1 POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME Daicel Corporation (JP) 2014-12-17 EP disclosed
CN-104093690-A Polyglycerin dialkyl or alkenyl ether, and cosmetic composition containing same DAICEL CORP 2014-10-08 CN disclosed
US-7947419-B2 Toner, developer, and image forming method RICOH COMPANY LIMITED (JP) 2011-05-24 US disclosed
EP-2048544-A1 Toner, developer and image forming method Ricoh Company, Ltd. (JP) 2009-04-15 EP disclosed
US-20090092917-A1 TONER, DEVELOPER, AND IMAGE FORMING METHOD RICOH COMPANY LIMITED (JP) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009619-A1 POLYGLYCERIN DIALKYL OR ALKENYL ETHER, AND COSMETIC COMPOSITION CONTAINING SAME DEGS1, DAGLA, MGLL LMNA 1991/4885FDPS 3560/4885GGPS1 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.